Mario Gabelli Bio Rad Laboratories, Inc. Transaction History

Gamco Investors, Inc. Et Al

$9 Billion
Q3 2024

A detailed history of Mario Gabelli (Gamco Investors, Inc. Et Al) transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Gamco Investors, Inc. Et Al holds 26,750 shares of BIO stock, worth $8.84 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

26,750

Previous 26,750 -0.0%

Holding current value

$8.84 Million

Previous $7.31 Million 22.52%

% of portfolio

0.1%

Previous 0.09%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$304.11 - $351.99 $129,246 - $149,595	-425 Reduced 1.56%	26,750 $9.25 Million
Q2 2023 Aug 10, 2023	SELL	$359.49 - $486.4 $30,556 - $41,344	-85 Reduced 0.31%	27,175 $10.3 Million
Q2 2022 Aug 12, 2022	SELL	$463.67 - $597.16 $46,367 - $59,716	-100 Reduced 0.37%	27,260 $13.5 Million
Q1 2022 May 13, 2022	SELL	$524.57 - $735.42 $52,457 - $73,542	-100 Reduced 0.36%	27,360 $15.4 Million
Q4 2021 Feb 11, 2022	SELL	$708.84 - $794.68 $70,884 - $79,468	-100 Reduced 0.36%	27,460 $20.7 Million
Q3 2021 Nov 12, 2021	SELL	$657.71 - $825.77 $85,502 - $107,350	-130 Reduced 0.47%	27,560 $20.6 Million
Q2 2021 Aug 13, 2021	SELL	$576.64 - $649.04 $28,832 - $32,452	-50 Reduced 0.18%	27,690 $17.8 Million
Q4 2020 Feb 05, 2021	SELL	$510.68 - $643.45 $485,146 - $611,277	-950 Reduced 3.31%	27,740 $16.2 Million
Q3 2020 Nov 06, 2020	SELL	$454.43 - $535.6 $31,810 - $37,492	-70 Reduced 0.24%	28,690 $14.8 Million
Q2 2020 Aug 13, 2020	SELL	$334.87 - $493.06 $1.09 Million - $1.61 Million	-3,262 Reduced 10.19%	28,760 $13 Million
Q4 2019 Feb 14, 2020	SELL	$319.73 - $374.2 $319,730 - $374,200	-1,000 Reduced 3.03%	32,022 $11.8 Million
Q3 2019 Nov 01, 2019	SELL	$304.55 - $345.24 $350,232 - $397,026	-1,150 Reduced 3.37%	33,022 $11 Million
Q2 2019 Aug 02, 2019	SELL	$286.93 - $312.59 $1.31 Million - $1.42 Million	-4,550 Reduced 11.75%	34,172 $10.7 Million
Q1 2019 May 02, 2019	SELL	$224.3 - $317.41 $112,150 - $158,705	-500 Reduced 1.27%	38,722 $11.8 Million
Q4 2018 Jan 30, 2019	SELL	$220.1 - $309.0 $129,859 - $182,310	-590 Reduced 1.48%	39,222 $9.11 Million
Q3 2018 Nov 02, 2018	SELL	$289.28 - $326.15 $665,343 - $750,145	-2,300 Reduced 5.46%	39,812 $12.5 Million
Q2 2018 Aug 10, 2018	SELL	$244.1 - $303.88 $488,200 - $607,760	-2,000 Reduced 4.53%	42,112 $12.2 Million
Q1 2018 May 09, 2018	SELL	$233.97 - $274.11 $620,020 - $726,391	-2,650 Reduced 5.67%	44,112 $11 Million
Q4 2017 Feb 02, 2018	SELL	$216.94 - $271.3 $1.17 Million - $1.47 Million	-5,400 Reduced 10.35%	46,762 $11.2 Million
Q3 2017 Nov 01, 2017	BUY	$212.27 - $242.28 $11.1 Million - $12.6 Million	52,162	52,162 $11.6 Million

Others Institutions Holding BIO

# of Institutions

456

Shares Held

18.2M

Call Options Held

19.5K

Put Options Held

13.9K

View Full List

About BIO-RAD LABORATORIES, INC.

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.14B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

More about BIO

Track Mario Gabelli's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamco Investors, Inc. Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Gamco Investors, Inc. Et Al and Mario Gabelli with notifications on news.

Account